# Naloxone Hydrochloride

NDC: 0093-2165
Generic name: Naloxone Hydrochloride
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SPRAY, METERED
Routes: NASAL
Marketing started: 20211222
Marketing ended: 20260630
FDA application: ANDA209522

## Active ingredients

- NALOXONE HYDROCHLORIDE: 4 mg/.1mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-2165"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-2165
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a72d8cf-3c24-47d8-94d1-4e175f2da264